// App-Quantinova.ai

: Differences in Predictors of Mortality and Resource Utilization Among Adult Patients with Acute Lymphocytic Leukemia and Acute Myeloid Leukemia

Researchers

Presenter

  • Manoj P Rai

Principal Investigators

  • Heather Laird-Fick

  • Prabhjot Singh Bedi

  • Justin D. Kaner

  • Samanjit Kaur Kandola

  • Shilpa Kavuturu

  • Nishant Tageja

  • Marwan S Abougergi

  • Stanley M. Marks

  • James B. Bussel

Medical Centers

  • Michigan State University, Lansing, MI

  • UPMC, Pittsburgh, PA

  • Department of Hematology/Oncology, New York Presbyterian/Weill Cornell Medical Center, New York, NY

  • Michigan State University, Lansing, MI

  • Wheeling Hospital, Monroeville, PA

  • Division of Gastroenterology, Department of Internal Medicine, University of South Carolina School of Medicine, Columbia, SC

  • UPMC Cancer Center, Pittsburgh, PA

  • Division of Pediatric Hematology/Oncology, Department of Pediatrics, New York Presbyterian Hosp. Weill Cornell Medical Center, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A